Alison Finger
Director/Board Member chez ADMA BIOLOGICS, INC.
Fortune : 158 664 $ au 31/03/2024
Profil
Alison C.
Finger is currently the Director at ADMA Biologics, Inc. She previously served as an Independent Non-Executive Director at Vascular Biogenics Ltd.
from 2021 to 2022.
Prior to that, she was the Managing Director at Bristol-Myers Squibb Australia Pty Ltd.
from 2007 to 2009.
Alison also held positions as a Director at Medicines Australia, Alliance for Regenerative Medicine, and Regenerative Medicine Foundation.
She served as an Independent Director at Decibel Therapeutics, Inc. from 2021 to 2023.
From 2015 to 2021, she was the Chief Commercial Officer at bluebird bio, Inc. Additionally, Alison was the VP-Global Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd.
from 2009 to 2014.
She completed her undergraduate degree at St. Lawrence University and holds an MBA from The Fuqua School of Business.
Ms. Finger's current job is Director at ADMA Biologics, Inc.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ADMA BIOLOGICS, INC.
0,01% | 26/02/2024 | 24 040 ( 0,01% ) | 158 664 $ | 31/03/2024 |
Postes actifs de Alison Finger
Sociétés | Poste | Début |
---|---|---|
ADMA BIOLOGICS, INC. | Director/Board Member | 28/09/2023 |
Anciens postes connus de Alison Finger
Sociétés | Poste | Fin |
---|---|---|
DECIBEL THERAPEUTICS, INC. | Director/Board Member | 22/09/2023 |
NOTABLE LABS, LTD. | Director/Board Member | 01/08/2022 |
BLUEBIRD BIO, INC. | Corporate Officer/Principal | 01/01/2021 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | 01/05/2014 |
Bristol-Myers Squibb Australia Pty Ltd.
Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Australia Pty Ltd. is a biopharmaceutical company that researches, develops and markets medicines for serious diseases. The company was founded in 1930 and is headquartered in Noble Park North, Australia. | Chief Executive Officer | 01/01/2009 |
Formation de Alison Finger
St. Lawrence University | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ADMA BIOLOGICS, INC. | Health Technology |
BLUEBIRD BIO, INC. | Health Technology |
DECIBEL THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
Vascular Biogenics Ltd.
Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
Bristol-Myers Squibb Australia Pty Ltd.
Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Australia Pty Ltd. is a biopharmaceutical company that researches, develops and markets medicines for serious diseases. The company was founded in 1930 and is headquartered in Noble Park North, Australia. | Health Technology |
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia. | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Regenerative Medicine Foundation
Regenerative Medicine Foundation Medical SpecialtiesHealth Technology The Regenerative Medicine Foundation is a non-profit organization that aims to accelerate the development of regenerative medicine to improve health and deliver cures. The non-profit company is based in Winston-Salem, NC. The foundation fosters strategic collaborations to achieve its mission and produces its flagship event, the World Stem Cell Summit. Additionally, the foundation honors leaders in the field through the Stem Cell and Regenerative Medicine Action Awards and promotes educational initiatives. | Health Technology |